The use of family history in public health practice: The epidemiologic view

Human Genome Epidemiology: Building the Evidence for Using Genetic Information to Improve Health and Prevent Disease: Second Edition

Volumn , Issue , 2010, Pages

  Valdez, Rodolfo ^a   Khoury, Muin J ^a,b   Yoon, Paula W ^c  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Disease risk factors; Family history; Genomics; Public health practice

Indexed keywords

EID: 84921258732     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195398441.003.0029     Document Type: Chapter

References (78)

1. Bennett RL. The Practical Guide to the Genetic Family History New York: Wiley-Liss Inc.; 1999.
2. Zeggini E, Scott LJ, Saxena R, Voight BF. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008; 40:638-645.
3. Frost WH. The familial aggregation of infectious diseases. Am J Public Health 1938; 28:7-13.
4. Suther S, Goodson P. Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature. Genet Med 2003; 5:70-76.
5. Bennett RL. The family medical history. Prim Care Clin Office Pract 2004; 31:479-495.
6. Yoon PW, Scheuner MT, Khoury MJ. Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med 2003; 24:128-135.
7. Mosconi L, Brys M, Switalski R, et al. Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci USA 2007; 104:19067-19072.
8. Goldfine AB, Beckman JA, Betensky RA, et al. Family history of diabetes is a major determinant of endothelial function. J Am Coll Cardiol 2006; 47:2456-2461.
9. Kao WHL, Hsueh WC, Rainwater DL, et al. Family history of type 2 diabetes is associated with increased carotid artery intimal-medial thickness in Mexican Americans. Diabetes Care 2005; 28:1882-1889.
10. Kerber RA, Slattery ML, Potter JD, Caan BJ, Edwards SL. Risk of colon cancer associated with a family history of cancer or colorectal polyps: the Diet, Activity, and Reproduction in Colon Cancer Study. Int J Cancer 1998; 78:157-160.
11. Goldfine AB, Bouche C, Parker RA, et al. Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. Proc Natl Acad Sci USA 2003; 100:2724-2729.
12. Rosenbaum M, Nonas C, Horlick M, et al. β-cell function and insulin sensitivity in early adolescence: association with body fatness and family history of type 2 diabetes mellitus. J Clin Endocrinol Metab 2004; 89:5469-5476.
13. Goran MI, Bergman RN, Avila Q, et al. Impaired glucose tolerance and reduced β-cell function in overweight latino children with a positive family history for type 2 diabetes. J Clin Endocrinol Metab 2004; 89:207-212.
14. Arslanian SA, Bacha F, Saad R, Gungor N. Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth. Diabetes Care 2005; 28:127-131.
15. Civitarese AE, Jenkinson CP, Richardson D, et al. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia 2004; 47:816-820.
16. Scheuner MT, Yoon PW, Khoury MJ. Contribution of Mendelian disorders to common chronic disease: opportunities for recognition, intervention, and prevention. Am J Med Genet C Semin Med Genet 2004; 125C:50-65.
17. Wattendorf DJ, Hadley DW. Family history: the three-generation pedigree. Am Fam Physician 2005; 72:441-448.
18. Hunt SC, Williams RR, Barlow GK. A comparison of positive family history definitions for defining risk of future disease. J Chronic Dis 1986; 39:809-821.
19. Kardia SL, Modell SM, Peyser PA. Family-centered approaches to understanding and preventing coronary heart disease. Am J Prev Med 2003; 24:143-151.
20. Silberberg JS, Wlodarczyk J, Fryer J, Robertson R, Hensley MJ. Risk associated with various definitions of family history of coronary heart disease. The Newcastle Family History Study II. Am J Epidemiol 1998; 147:1133-1139.
21. Bertuzzi M, Negri E, Tavani A, La Vecchia C. Family history of ischemic heart disease and risk of acute myocardial infarction. Prev Med 2003; 37:183-187.
22. Scheuner MT, Whitworth WC, McGruder H, Yoon PW, Khoury MJ. Expanding the definition of a positive family history for early-onset coronary heart disease. Genet Med 2006; 8:491-501.
23. Brown DW, Giles WH, Burke W, Greenlund KJ, Croft JB. Familial aggregation of early-onset myocardial infarction. Community Genet 2002; 5:232-238.
24. Sesso HD, Lee IM, Gaziano JM, Rexrode KM, Glynn RJ, Buring JE. Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation 2001; 104:393-398.
25. Vaidya D, Yanek LR, Moy TF, Pearson TA, Becker LC, Becker DM. Incidence of coronary artery disease in siblings of patients with premature coronary artery disease: 10 years of follow-up. Am J Cardiol 2007; 100:1410-1415.
26. Murabito JM, Pencina MJ, Nam BH, et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA 2005; 294:3117-3123.
27. Friedlander Y, Arbogast P, Schwartz SM, et al. Family history as a risk factor for early onset myocardial infarction in young women. Atherosclerosis 2001; 156:201-207.
28. Liao D, Myers R, Hunt S, et al. Familial history of stroke and stroke risk. The Family Heart Study. Stroke 1997; 28:1908-1912.
29. Tentschert S, Greisenegger S, Wimmer R, Lang W, Lalouschek W. Association of parental history of stroke with clinical parameters in patients with ischemic stroke or transient ischemic attack. Stroke 2003; 34:2114-2119.
30. Jousilahti P, Rastenyte D, Tuomilehto J, Sarti C, Vartiainen E. Parental history of cardiovascular disease and risk of stroke. A prospective follow-up of 14371 middle-aged men and women in Finland. Stroke 1997; 28:1361-1366.
31. Khaw KT, Barrett-Connor E. Family history of stroke as an independent predictor of ischemic heart disease in men and stroke in women. Am J Epidemiol 1986; 123:59-66.
32. Kim H, Friedlander Y, Longstreth WT, Jr, Edwards KL, Schwartz SM, Siscovick DS. Family history as a risk factor for stroke in young women. Am J Prev Med 2004; 27:391-396.
33. Wannamethee SG, Shaper AG, Ebrahim S. History of parental death from stroke or heart trouble and the risk of stroke in middle-aged men. Stroke 1996; 27:1492-1498.
34. Jood K, Ladenvall C, Rosengren A, Blomstrand C, Jern C. Family history in ischemic stroke before 70 years of age: the Sahlgrenska Academy Study on Ischemic Stroke. Stroke 2005; 36:1383-1387.
35. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS. Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 2003; 34:1364-1369.
36. Mvundura M, McGruder H, Khoury MJ, Valdez R, Yoon PW. Family history as a risk factor for early-onset stroke/transient ischemic attack among U.S. Adults. Public Health Genomics (DOI:10.1159/000209879) Published Online: March 23, 2009.
37. Flossmann E, Rothwell PM. Family history of stroke in patients with transient ischemic attack in relation to hypertension and other intermediate phenotypes. Stroke 2005; 36:830-835.
38. Feinberg WM, Albers GW, Barnett HJM, et al. Guidelines for the management of transient ischemic attacks. Stroke 1994; 25:1320-1335.
39. Arnett DK. Heritability of hypertension and target organ damage (Chapter A78). In: Izzo JL, Black HR, Goodfriend TL, eds. Hypertension Primer: The Essentials of High Blood Pressure Lippincott: Williams & Wilkins; 2003:227.
40. Seidlerová J, Bochud M, Staessen JA, et al. Heritability and intrafamilial aggregation of arterial characteristics. J Hypertens 2008; 26:721-728.
41. Michos ED, Vasamreddy CR, Becker DM, et al. Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis. Am Heart J 2005; 150:1276-1281.
42. Nasir K, Budoff MJ, Wong ND, et al. Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2007; 116:619-626.
43. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007; 297:611-619.
44. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007; 335 (7611):136.
45. Harrison TA, Hindorff LA, Kim H, et al. Family history of diabetes as a potential public health tool. Am J Prev Med 2003; 24:152-159.
46. Knowler WC, Pettitt DJ, Savage PJ, Bennett PH. Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol 1981; 113:144-156.
47. Bjørnholt JV, Erikssen G, Liestøl K, Jervell J, Thaulow E, Erikssen J. Type 2 diabetes and maternal family history: an impact beyond slow glucose removal rate and fasting hyperglycemia in low-risk individuals? Results from 22.5 years of follow-up of healthy nondiabetic men. Diabetes Care 2000; 23:1255-1259.
48. Meigs JB, Cupples LA, Wilson PW. Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes 2000; 49:2201-2207.
49. Annis AM, Caulder MS, Cook ML, Duquette D. Family history, diabetes, and other demographic and risk factors among participants of the National Health and Nutrition Examination Survey 1999-2002. Prev Chronic Dis 2005; 2(2):A19.
50. Mitchell BD, Valdez R, Hazuda HP, Haffner SM, Monterrosa A, Stern MP. Differences in the prevalence of diabetes and impaired glucose tolerance according to maternal or paternal history of diabetes. Diabetes Care 1993; 16:1262-1267.
51. Lin RS, Lee WC, Lee YT, Chou P, Fu CC. Maternal role in type 2 diabetes mellitus: indirect evidence for a mitochondrial inheritance. Int J Epidemiol 1994; 23:886-890.
52. Hariri S, Yoon PW, Qureshi N, Valdez R, Scheuner MT, Khoury MJ. Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med 2006; 8:102-108.
53. Valdez R, Yoon PW, Liu T, Khoury MJ. Family history and prevalence of diabetes in the U.S. population: the 6-year results from the National Health and Nutrition Examination Survey (1999-2004). Diabetes Care 2007; 10:2517-2522.
54. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008. Available at. Accessed October 15, 2008.
55. Ramachandran A, Snehalatha C, Vijay V, Wareham NJ, Colagiuri S. Derivation and validation of diabetes risk score for urban Asian Indians. Diabetes Res Clin Pract 2005; 70:63-70.
56. Aekplakorn W, Bunnag P, Woodward M, et al. A risk score for predicting incident diabetes in the Thai population. Diabetes Care 2006; 29:1872-1877.
57. Al-Lawati JA, Tuomilehto J. Diabetes risk score in Oman: a tool to identify prevalent type 2 diabetes among Arabs of the Middle East. Diabetes Res Clin Pract 2007; 77:438-444.
58. Glümer C, Carstensen B, Sandbæk A, Lauritzen T, Jørgensen T, Borch-Johnsen K. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 2004; 27:727-733.
59. Schmidt MI, Duncan BB, Bang H, et al. Identifying individuals at high risk for diabetes: the atherosclerosis risk in communities study. Diabetes Care 2005; 28:2013-2018.
60. Ruige JB, de Neeling JN, Kostense PJ, Bouter LM, Heine RJ. Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 1997; 20:491-496.
61. American Diabetes Association. Diabetes Risk Calculator. Available at. Accessed October 15, 2008.
62. Rathmann W, Martin S, Haastert B, et al. Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000. Arch Intern Med 2005; 165:436-441.
63. Glümer C, Vistisen D, Borch-Johnsen K, Colagiuri S. Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care 2006; 29:410-414.
64. Norris SL, Kansagara D, Bougatsos C, Fu R. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2008; 148:855-868.
65. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2004; 27:S11-S14.
66. Murff HJ, Rothman RL, Byrne DW, Syngal S. The impact of family history of diabetes on glucose testing and counseling behavior in primary care. Diabetes Care 2004; 27:2247-2248.
67. Baptiste-Roberts K, Gary TL, Beckles GL, et al. Family history of diabetes, awareness of risk factors, and health behaviors among African Americans. Am J Public Health 2007; 97:907-912.
68. Qureshi N, Kai J. Informing patients of familial diabetes mellitus risk: How do they respond? A cross-sectional survey. BMC Health Serv Res 2008; 8:37.
69. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348:919-932.
70. Peto J, Collins N, Barfoot R, et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 1999; 91:943-949.
71. Acheson LS, Zyzanski SJ, Stange KC, Deptowicz A, Wiesner GL. Validation of a self-administered, computerized tool for collecting and displaying the family history of cancer. J Clin Oncol 2006; 24:5395-5402.
72. Sweet KM, Bradley TL, Westman JA. Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol 2002; 20:528-537.
73. Nelson HD, Huffman LH, Fu R, Harris EL. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2005; 143:362-379.
74. Palomaki GE, McClain MR, Steinort K, Sifri R, LoPresti L, Haddow JE. Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21-to 55-year-old women. Genet Med 2006; 8:161-168.
75. American Cancer Society. Cancer Prevention & Early Detection Facts & Figures 2007 Atlanta: American Cancer Society; 2007.
76. Audrain-McGovern J, Hughes C, Patterson F. Effecting behavior change: awareness of family history. Am J Prev Med 2003; 24:183-189.
77. Tyagi A, Morris J. Using decision analytic methods to assess the utility of family history tools. Am J Prev Med 2003; 24:199-207.
78. Ramsey SD, Burke W, Pinsky L, Clarke L, Newcomb P, Khoury MJ. Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis. Cancer Epidemiol Biomarkers Prev 2005; 14:2494-2500.